R2P Destination Slender GS-R6ST1C10WRecalls & reported problems
Terumo Medical Corporation · R2P Destination Slender Guiding Sheath · Class 2
All models of R2P Destination Slender (6)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00389701012353), received between Feb 17, 2022 and Oct 23, 2024 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break2
- Physical Resistance/Sticking2
- Difficult to Remove1
- Leak/Splash1
- Material Separation1
- Material Split, Cut or Torn1
Patient problems
- Foreign Body In Patient2
- No Clinical Signs, Symptoms or Conditions2
- Calcium Deposits/Calcification1
- Cramp(s) /Muscle Spasm(s)1
- Obstruction/Occlusion1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 23, 2024Break; Difficult to Remove; Break; Difficult to Remove
THE USER FACILITY REPORTED THAT THE DESTINATION SLENDER SHEATH UNRAVELED IN THE RADIAL ARTERY DUE TO SPASM. PATIENT HAD TO GO FOR SURGERY AND THE DEVICE WAS REMOVED DURING SURGERY. THE PROCEDURE BEING PERFORMED WAS A SUPERIOR MESENTERIC ARTERY (SMA) STENTING. THE PATIENT WAS FINE PRE PROCEDURE, ALERT AND AWAKE. THE ESTIMATED BLOOD LOSS WAS LESS THAN 250CC. ADDITIONAL INFORMATION WAS RECEIVED ON 25SEPT2024: RESISTANCE WAS ENCOUNTERED UPON REMOVAL DUE TO SPASM. WE INFLATED BLOOD PRESSURE (BP) CUFF HIGHER UP THE ARM, GAVE MORE NITRO, PATIENT WAS SEDATE AS WE HAD ANESTHESIOLOGIST FOR THE CASE. THE PATIENT WAS STABLE. AFTER CUT-DOWN AND RETRIEVING THE SHEATH THEY GAINED ACCESS HIGHER IN THE BRACHIAL AND THE SUPERIOR MESENTERIC ARTERY (SMA) STENTING WAS COMPLETED. THE PATIENT WAS A SKINNY OLDER LADY.
Patient problems: Cramp(s) /Muscle Spasm(s); Foreign Body In Patient
MAUDE report 20516008 ↗MalfunctionMay 3, 2024Break; Break
THE USER FACILITY REPORTED THAT THE DOCTOR PERFORMED AN R2P PROCEDURE. THE LEFT RADIAL WAS SMALL, AROUND 2.0 MM. THE DOCTOR WAS AN EXPERIENCE R2P OPERATOR AND KNEW THAT IT WAS SMALL, HOWEVER HE DEEMED IT SAFE. THEY WERE ABLE TO SUCCESSFULLY TREAT THE RIGHT SUPERFICIAL FEMORAL ARTERY (SFA) WITH PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA), THE RIGHT EXTERNAL ILIAC WITH SHOCKWAVE AND STENT. HE THEN TREATED LEFT COMMON ILIAC WITH STENT. HE REMOVED THE SHEATH WITH THE DILATOR AND .035 GUIDEWIRE ADVANTAGE (GWA). HE EXPERIENCED SPASM WHICH HE ANTICIPATED. THE PATIENT WAS UNDER MONITORED ANESTHESIA CARE (MAC). HE FELT RESISTANCE HOWEVER DEEMED IT SAFE TO REMOVE THE SHEATH. THE SHEATH WAS SUCCESSFULLY REMOVED, HOWEVER, THERE WAS SOME SEPARATION IN THE SHEATH ONCE IT WAS REMOVED. THERE WAS NOTHING LEFT BEHIND AND NO COMPLICATIONS. THERE WAS NO ADVERSE EVENT AND NO BLOOD LOSS. TYPE OF PROCEDURE PERFORMED WAS A RIGHT AND LEFT ILIAC INTERVENTION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19237861 ↗InjuryApr 1, 2023Material Split, Cut or Torn; Physical Resistance/Sticking; Material Split, Cut or Torn; Physical Resistance/Sticking
THE USER FACILITY REPORTED THAT WHEN ATTEMPTING TO REMOVE THE INVOLVED DESTINATION SLENDER SHEATH FROM THE RADIAL ARTERY, THE SHEATH HUB SPLIT APART FROM THE SHEATH SHAFT. THE PHYSICIAN SAID THAT HE DID NOT PULL ANY OF THE SHEATH SHAFT OUT OF WRIST PRIOR TO INFLATING THE TR BAND. THEREFORE, THE FULLY INFLATED TR BAND HAD TOO MUCH FRICTION WITH THE SHEATH WHILE REMOVING THE SHEATH WHICH SEVERED THE SHEATH HUB FROM THE SHEATH SHAFT. THE RESISTANCE WAS NOT CREATED FROM RADIAL ARTERY SPASM PER THE PHYSICIAN. TO REMOVE THE ENTIRE SHEATH, THE PHYSICIAN PERFORMED CUT DOWN SURGERY TO REMOVE THE SHEATH. THIS WAS PERFORMED SUCCESSFULLY. PATIENT CONDITION WAS STABLE. THE EVENT OCCURRED INTRA- OPERATIVE. THE PROCEDURE OUTCOME WAS SUCCESSFUL. SURGICAL INTERVENTION WAS REQUIRED AS A CUT DOWN SURGERY WAS DONE ON THE RADIAL ARTERY TO REMOVE THE SHEATH. ADDITIONAL INFORMATION WAS RECEIVED ON 08 MARCH 2023: THE PROCEDURE PERFORMED FOR THE PATIENT WAS LOWER EXTREMITY ANGIOGRAM. THE DOCTOR STATED THERE WAS NO RADIAL ARTERY SPASM, HE SAID THE RADIAL ARTERY WAS NOT DAMAGED AND THIS WAS CAUSED BY TENSION BETWEEN FULLY INFLATED TR BAND AND DESTINATION SLENDER SHEATH. HE DID NOT PULL THE SHEATH OUT AT ALL
Patient problems: Obstruction/Occlusion
MAUDE report 16660737 ↗MalfunctionAug 21, 2022Leak/Splash; Leak/Splash
THE USER FACILITY REPORTED THAT THE DESTINATION SLENDER GUIDING SHEATH SPRAYED CONTRAST ON TO PHYSICIAN AND TECHNOLOGIST UPON HAND INJECTING CONTRAST THROUGH THE SHEATH. THE SHEATH VALVE SPRAYS CONTRAST AND COULD ALSO BLOOD CAN SPRAY ALL OVER. THE PATIENT WAS STABLE, AND THE PROCEDURE WAS SUCCESSFUL. ADDITIONAL INFORMATION WAS RECEIVED ON (B)(6) 2022: THE TYPE OF PROCEDURE BEING PERFORMED WAS A RADIAL TO PERIPHERAL ANGIOPLASTY WITH STENT PLACEMENT. THE PROCEDURE WAS COMPLETED USING THE DEVICE. SPRAYS FROM THE VALVE UPON HAND INJECTING CONTRAST MAY HAVE COME OUT FROM LEAFLETS THAT SUPPORT THE WIRE IN CENTER OF SHEATH. THERE WAS NO NOTICEABLE DAMAGE TO THE DEVICE. THERE WAS NO BLOOD LOSS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15263499 ↗InjuryFeb 17, 2022Material Separation; Physical Resistance/Sticking; Material Separation; Physical Resistance/Sticking
THE USER FACILITY REPORTED THAT AFTER THE PROCEDURE WAS COMPLETE, THE DOCTOR WAS WITHDRAWING THE R2P GUIDING SHEATH WITH THE DILATOR IN IT. WHEN THE DOCTOR GOT TO THE DISTAL PART OF THE SHEATH THAT WAS IN THE BRACHIAL ARTERY, THE DOCTOR STOPPED AND WITHDREW THE DILATOR BECAUSE THE DOCTOR WANTED TO GIVE MORE NITRO. THE DOCTOR THEN PROCEEDED TO PULL ON THE SHEATH, WITHOUT THE DILATOR IN IT, AND MET RESISTANCE. THE DOCTOR THEN PULLED MUCH HARDER, AND THE SHEATH SEPARATED LEAVING A DISTAL PIECE OF THE SHEATH IN THE RADIAL ARTERY. ADDITIONAL INFORMATION WAS RECEIVED ON 28 JAN 2022: THE PROCEDURE PERFORMED WAS A LEFT COMMON ILIAC PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA), A LEFT SUPERFICIAL FEMORAL ARTERY (SFA) PTA, STENTING, AND A LEFT POPLITEAL PTA. THE PATIENT HAS GANGRENOUS ANKLE AND FOOT, AND THIS PROCEDURE WAS DONE TO ENSURE GOOD BLOOD FLOW PRIOR TO A BELOW KNEE AMPUTATION. THE DILATOR WAS REMOVED TO GIVE NITRO TO ALLEVIATE PERCEIVED SPASM. THE PATIENT WAS TAKEN INTO SURGERY WITHIN TWO HOURS AND HAD ULNAR PULSE AND PULSE OXYGEN (OX) READING ON THE RIGHT HAND (WHERE THE PROCEDURE WAS DONE). THE VASCULAR SURGEON FOUND THE SHEATH TO BE LODGED IN THE RADIAL ARTERY WITH SOME CALCIUM A
Patient problems: Calcium Deposits/Calcification; Foreign Body In Patient
MAUDE report 13548902 ↗
Other INTRODUCER, CATHETER devices
- VIZIGO D138502Biosense Webster Inc · INTRODUCER, CATHETER2 recalls4 deaths2,839 reports
- VIZIGO D138501Biosense Webster Inc · INTRODUCER, CATHETER2 recalls2 deaths2,005 reports
- Swartz™ 407451St. Jude Medical, Inc. · INTRODUCER, CATHETER5 deaths728 reports
- Edwards eSheath+ Introducer set 914ESPEdwards Lifesciences LLC · Introducer, Catheter22 deaths532 reports
- Fast-Cath™ 406849St. Jude Medical, Inc. · INTRODUCER, CATHETER420 reports
- VIZIGO D138503Biosense Webster Inc · INTRODUCER, CATHETER362 reports
- Agilis™ G408318St. Jude Medical, Inc. · INTRODUCER, CATHETER333 reports
- Agilis™ NxT Steerable Introducer Dual-Reach™ SI-1371-MSt. Jude Medical, Inc. · Introducer, catheter1 death301 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page